Related by context. All words. (Click for frequent words.) 74 forodesine 73 elotuzumab 71 INCB# [001] 70 alvespimycin 69 Dapagliflozin 69 Bicifadine 69 phase IIb 69 Androxal TM 69 neratinib 69 Phase Ib study 69 nalbuphine ER 68 Phase 2b clinical 68 AeroLEF TM 68 phase IIa clinical 68 rNAPc2 68 AEG# 68 PDE4 inhibitor 68 LymphoStat B 68 PEG Interferon lambda 68 HuMax EGFr 68 IAP inhibitors 68 sargramostim 68 pertuzumab 68 enzastaurin 67 HGS# 67 Phase 1b trial 67 Panzem R 67 TBC# 67 PEG PAL 67 lesinurad 67 Phase 1a clinical 67 GALNS 67 KNS # 67 Plicera 67 Archexin 67 ELACYT 67 atrasentan 67 Phase IIa trials 67 Zerenex 67 CR# vcMMAE 67 PNP inhibitor 67 oral prodrug 67 PREOS R 67 talactoferrin 67 CD# CEA 67 R#/MEM # 67 PLK1 SNALP 67 OXi# 67 Traficet EN 66 AEGR 66 MGCD# [001] 66 deforolimus 66 RDEA# 66 JAK inhibitor 66 YONDELIS 66 PRT# 66 evaluating tivozanib 66 pomalidomide 66 phase IIa 66 Panzem R NCD 66 ganetespib 66 ISIS # 66 vidofludimus 66 Cloretazine R VNP#M 66 PEG SN# 66 Phase Ib 66 teriflunomide 66 tanespimycin 66 PS# [001] 66 TELCYTA 66 docetaxel Taxotere R 66 ALN PCS 66 ALN TTR# 66 metaglidasen 66 cannabinor 65 Tarceva TM 65 HQK 65 phase IIb clinical 65 elagolix 65 confirmatory Phase 3 65 IMA# 65 ularitide 65 TKM ApoB 65 Phenoptin 65 HGS ETR1 65 TLK# 65 APD# 65 danoprevir 65 CoFactor 65 Fibrillex TM 65 huC# DM4 65 Factor VIIa 65 Ocrelizumab 65 sapacitabine 65 Mipomersen 65 Azedra ™ 65 phase IIb trial 65 Virulizin R 65 Vicriviroc 65 bicifadine 65 Phase IIb trials 65 dacetuzumab 65 OncoVEX GM CSF 65 PSMA ADC 65 FOLFOX6 chemotherapy regimen 65 Phase 2a trial 65 Phase 1b 65 orally administered inhibitor 65 mGluR5 NAM 65 CEQ# 65 oral salmon calcitonin 65 PRX # 65 PXD# 65 TASKi2 65 Azedra TM 65 Phase IIa trial 65 DDP# 65 lintuzumab 65 mertansine 65 Tezampanel 65 teduglutide 65 KRN# 65 Aurora kinase inhibitor 65 Phase IIIb clinical 65 CTAP# Capsules 65 selective androgen receptor modulator 65 Phase Ib clinical 65 refractory chronic lymphocytic 65 XmAb# 65 Locteron 65 CYT# potent vascular disrupting 65 Vilazodone 65 ApoB SNALP 65 Velcade bortezomib 65 virus HCV protease inhibitor 64 Phase IIb clinical 64 SAR# [004] 64 Oral NKTR 64 evaluating satraplatin 64 ELADUR 64 oral ridaforolimus 64 eltrombopag 64 CCX# 64 atacicept 64 vilazodone 64 HspE7 64 ORENCIA R 64 Chemophase 64 Golimumab 64 TELINTRA 64 NVA# 64 Triolex 64 HGS ETR2 64 GAMMAGARD 64 Dacogen injection 64 romidepsin 64 HCD# [002] 64 Vitaxin 64 ALN TTR 64 XL# XL# 64 diabetic neuropathic pain 64 tiapamil 64 BRIM3 64 bardoxolone 64 investigational humanized monoclonal antibody 64 Phase Ib II 64 pivotal Phase III 64 registrational trial 64 perifosine 64 Phase 2a 64 SPRYCEL ® 64 vicriviroc 64 Pimavanserin 64 Quinamed 64 Reverset 64 LymphoStat B TM 64 generation purine nucleoside 64 XL# XL# XL# XL# 64 non nucleoside inhibitor 64 Phase #b/#a 64 ocrelizumab 64 LY# [003] 64 trastuzumab DM1 T DM1 64 NGX# 64 febuxostat 64 thymalfasin 64 R#/MEM 64 OvaRex ® MAb 64 relapsed refractory multiple myeloma 64 sorafenib tablets 64 MAGE A3 ASCI 64 Alocrest 64 dextofisopam 64 mipomersen 64 alvimopan 64 HuLuc# 64 Trofex TM 64 adalimumab Humira 64 Pegasys ® 64 Romidepsin 64 bosutinib 64 RSD# oral 64 Nasulin 64 novel VDA molecule 64 EOquin 64 LibiGel ® 64 MAP# 64 Ozarelix 64 celgosivir 64 Nexavar ® 64 Lenocta 64 HCV protease inhibitor 64 Phase 2a clinical 64 Urocortin 2 64 Pazopanib 63 BRIM2 63 Aurexis 63 JAK2 inhibitor 63 radiation sensitizer 63 EndoTAGTM 1 63 compound INCB# 63 Clolar ® 63 Cimzia TM 63 RGB # 63 Alzhemed TM 63 Phase 2b trial 63 BLA filing 63 PREOS 63 Dyloject TM 63 ALN RSV# 63 canakinumab 63 eprotirome 63 Phase IIB 63 Targretin 63 phase Ib 63 UVIDEM 63 metastatic hormone refractory 63 posaconazole 63 CORT # 63 sunitinib malate 63 PANVAC VF 63 anticancer compound 63 CIMZIA ™ 63 trastuzumab Herceptin R 63 RELOVAIR ™ 63 Phase IIb clinical trials 63 FOLOTYN ® 63 severe hypercholesterolemia 63 Asentar 63 lintuzumab SGN 63 XL# [003] 63 sorafenib Nexavar 63 BENLYSTA ® 63 seliciclib CYC# 63 AVE# 63 budesonide foam 63 GSK# [002] 63 midstage clinical 63 Xelox 63 otelixizumab 63 Insegia 63 brivaracetam 63 Safinamide 63 pegylated interferons 63 Anturol TM 63 opioid induced bowel dysfunction 63 DOS# 63 Pivotal Phase III 63 RhuDex ® 63 Dasatinib 63 Elagolix 63 ASA# 63 OvaRex R 63 Xcytrin R 63 nonclinical studies 63 CYT# 63 Allovectin 7 63 PDX pralatrexate 63 PD LID 63 Gemzar ® 63 regorafenib 63 Amplimexon 63 Phase 2b study 63 Phase IIb trial 63 Phase III clinical trials 63 NOX E# 63 SUCCEED trial 63 mapatumumab 63 Phase IIa 63 lexidronam injection 63 GLP toxicology studies 63 oral picoplatin 63 EndoTAG TM -1 63 Phase IIb 63 tenofovir emtricitabine 63 lomitapide 63 pradefovir 63 volociximab 63 Fodosine 63 HuMax CD4 63 Zolinza 63 Phase IIb Trial 63 PSN# [002] 63 incyclinide 63 Hyphanox 63 ICA # 63 ongoing Phase 1b 63 Pertuzumab 63 PROSTVAC VF 63 Xeloda ® 63 Azedra 63 Phase III 63 TOCOSOL Paclitaxel 63 davalintide 63 registrational 62 custirsen 62 iclaprim 62 daclizumab 62 baminercept 62 acyclovir Lauriad R 62 MGd 62 INCB# [002] 62 Xanafide 62 BAY #-# 62 Cloretazine ® 62 Zemplar Capsules 62 T Pred 62 Valdoxan 62 phase IIb study 62 MAXY alpha 62 Phase III Pivotal 62 Ramoplanin 62 Glufosfamide 62 eniluracil 62 investigational protease inhibitor 62 histone deacetylase HDAC inhibitor 62 dextromethorphan quinidine 62 GSK# [001] 62 preclinical studies 62 LUMINATE 62 Panzem 62 Ophena TM 62 CRx 62 APPRAISE 62 Boceprevir 62 Nanobody 62 Tesetaxel 62 cilengitide 62 Aflibercept 62 ANYARA 62 EOquin TM 62 ProLindac 62 LymphoStat B belimumab 62 glufosfamide 62 SIMCOR 62 Nuvion 62 Aliskiren 62 mGluR2 NAM 62 velafermin 62 SILENOR 62 RG# [001] 62 Shigamabs ® 62 aleglitazar 62 tramiprosate Alzhemed TM 62 refractory gout 62 Phase 2b Clinical Trial 62 Proellex TM 62 leading oral taxane 62 metformin sulfonylurea 62 MAXY G# 62 maximally tolerated dose 62 Pemetrexed 62 methylnaltrexone 62 ofatumumab 62 evaluating mipomersen 62 CDP# 62 Phase 2b clinical trials 62 goserelin 62 LEUKINE 62 AZD# 62 Carfilzomib 62 THR beta agonist 62 Viprinex TM 62 Atrasentan 62 Zenvia ™ 62 HuMax CD# 62 Amrubicin 62 Cimzia ® certolizumab pegol 62 OMP #M# 62 preclinical 62 ThGRF 62 Hsp# Inhibitor 62 OMNARIS HFA 62 torezolid phosphate 62 MKC# MT 62 MOZOBIL 62 telomerase therapeutic 62 Ambrisentan 62 GLYX 62 Capesaris 62 Restanza 62 ALN VSP 62 SERMs 62 adecatumumab 62 Alvesco R 62 paclitaxel Taxol ® 62 aplindore 62 XL# XL# XL# 62 miconazole Lauriad ® 62 HCV polymerase inhibitors 62 Solazed 62 RhuDex 62 Phase III clinical 62 APTIVUS 62 Virulizin ® 62 PEGPH# 62 Omnitarg 62 Locteron ® 62 SNT MC# 62 CB2 selective receptor agonist 62 PHX# 62 Spiegelmer ® 62 Muraglitazar 62 Ixempra 62 CD3 monoclonal antibody 62 Allovectin 7 R 62 tezampanel 62 bortezomib Velcade 62 reslizumab 62 bremelanotide 62 HCV RESPOND 2 62 R roscovitine 62 Febuxostat 62 Darusentan 62 MYDICAR ® 62 CG# [003] 62 Leukine ® 62 Zenvia Phase III 62 HCV SPRINT 62 Delafloxacin 62 aripiprazole Abilify 62 MEK inhibitor 62 ITAX 62 Saforis 62 thetreatment 62 Bezielle 62 Fx #A 62 lumiliximab 62 ixabepilone 62 Ostarine 62 investigational compound 62 Genz # 62 delafloxacin 62 zileuton IV 62 lenalidomide Revlimid R 62 #th Annual Interscience 62 MYDICAR 62 Bortezomib 62 TMC# [002] 62 SYN# 62 Novolimus 62 XL# anticancer compounds 62 CIMZIA TM 62 HERmark 62 visilizumab 62 ProSavin 62 novel histone deacetylase 62 Pivotal Phase 62 plus Copegus R 62 blinatumomab 62 ZYBRESTAT 62 microplasmin 62 receptor tyrosine kinase inhibitor 62 APEX PD 62 IND enabling 62 TKB# 62 epothilone 62 NP2 Enkephalin 62 FASLODEX 62 safinamide 62 Aryplase 62 Avanafil 62 TRAIL receptor antibodies 61 mTOR inhibitor 61 IV APAP 61 proteasome inhibitor 61 6R BH4 61 IL# PE#QQR 61 HER2 positive metastatic breast 61 pralatrexate 61 Phase 2b 61 desvenlafaxine succinate 61 trastuzumab emtansine T DM1 61 Actilon 61 JAK1 61 Oxypurinol 61 pramlintide 61 obatoclax 61 REMUNE R 61 docetaxel Taxotere 61 Cloretazine 61 vosaroxin 61 integrin inhibitor 61 Symadex 61 AVOREN 61 PROSTVAC TM 61 ATL# [001] 61 Thiarabine 61 oxymorphone ER 61 Onrigin 61 Sym# 61 antibody MAb 61 telaprevir VX 61 PCK# 61 Seliciclib 61 isoform selective 61 BEMA Buprenorphine 61 IND submission 61 ENMD # 61 Initiate Phase 61 ozarelix 61 SinuNase TM 61 TACI Ig 61 romidepsin novel 61 Omacetaxine 61 rilonacept 61 Tyrima 61 albinterferon alfa 2b 61 Cethromycin 61 Phase #b/#a trial 61 NXL# 61 rindopepimut 61 Tipranavir 61 cediranib 61 Sulonex 61 Dalbavancin 61 trodusquemine 61 R sorafenib tablets 61 omiganan 61 Abiraterone acetate 61 Tanespimycin 61 tezampanel NGX# 61 Voreloxin 61 DXL# 61 thalidomide Thalomid 61 Imprime PGG 61 ADX# 61 Firazyr 61 phase 2a 61 arzoxifene 61 RLY# 61 VEGF Trap 61 Copegus R 61 AZILECT R 61 bazedoxifene conjugated estrogens 61 Rigel R# 61 Marqibo 61 ponatinib 61 SCH # 61 Phase IIa clinical trials 61 Phase #/#a trial 61 ZEGERID Capsules 61 vorinostat 61 zonisamide SR 61 methylnaltrexone bromide 61 OMNARIS Nasal Spray 61 galiximab 61 R# #mg BID 61 pharmacokinetic PK 61 Stedivaze 61 alemtuzumab Campath 61 TASKi3 61 Personalized Immunotherapy 61 JAK2 inhibitors 61 albiglutide 61 Campath alemtuzumab 61 Rescula 61 CIMZIA TM certolizumab pegol 61 mGluR5 negative 61 REG2 61 MLN# 61 MoxDuo IR 61 Ixabepilone 61 ATL/TV# 61 ALN HPN 61 bifeprunox 61 TRILIPIX 61 Lu AA# 61 AP# [003] 61 Exelixis XL# 61 Nexavar sorafenib 61 DEB# 61 Targretin capsules 61 acyclovir Lauriad ® 61 Radezolid 61 ACTEMRA TM 61 SILENOR TM 61 PI3K/Akt pathway inhibitor 61 AVN# [001] 61 GW# [003] 61 non nucleoside HCV 61 Epratuzumab 61 BRAF inhibitor 61 Tekturna HCT 61 MYCAMINE 61 peripherally acting 61 investigational monoclonal antibody 61 adecatumumab MT# 61 relapsed multiple myeloma 61 boosted protease inhibitor 61 Aplidin 61 azilsartan medoxomil 61 GATTEX TM 61 Synavive 61 candesartan cilexetil 61 Bazedoxifene 61 APOPTONE 61 QVA# 61 epigenetic therapies 61 octreotide implant 61 BARACLUDE R 61 initiate Phase IIb 61 ruxolitinib 61 Myocet 61 picoplatin 61 aflibercept VEGF Trap 61 VA# [002] 61 ADVANCE PD 61 Empatic 61 refractory AML 61 MEND CABG 61 ulimorelin 61 targeted radiotherapeutic 61 dirucotide 61 GRN#L 61 Urocidin 61 Besivance 61 GVAX ® 61 ZOLINZA 61 Aplidin R 61 QLT# 61 TNF Tumor Necrosis Factor 61 faropenem 61 CDAD Clostridium difficile 61 CYC# 61 IRX 2 61 Randomized Phase 61 Vandetanib 61 Cleviprex TM clevidipine 61 Proxinium TM 61 palifosfamide 61 ANAVEX #-# [003] 61 zanolimumab 61 rALLy clinical trial 61 entinostat 61 Perifosine 61 Veronate 61 OncoVEX 61 Degarelix 61 Varespladib 61 Sapacitabine 61 abatacept Orencia 61 aclidinium 61 Tamibarotene 61 Doxil 61 velaglucerase alfa 61 CCR9 antagonist 61 Aptivus ® 61 Synavive ™ 61 MERLIN TIMI 61 Zenvia TM 61 Laquinimod 61 relapsed MM 61 Afatinib 61 SUTENT ® 61 Pruvel 61 Phase #b/#a clinical 61 Annamycin 61 liprotamase 61 phase III isavuconazole 61 Interferon beta 1a 61 muraglitazar 61 darusentan 61 Serada 61 Solazed TM 61 Hepatitis C HCV 61 Silodosin 61 Phase III Clinical Trials 61 MAA submission 61 desvenlafaxine 61 MKC# MKC# PP 61 orally bioavailable 61 interferon gamma 1b 61 Zybrestat 61 Lixivaptan 61 GAP #B# 61 CBLC# 61 MDV# 61 confirmatory Phase III 61 initiate Phase 2b 61 Tasimelteon 61 nitazoxanide 61 EDEMA3 61 belinostat 61 ribavirin Copegus 61 metastatic castration resistant 61 tesmilifene 61 QNEXA ® 61 Q#IR 61 riociguat 61 Corlux 61 Panzem NCD 61 bardoxolone methyl 61 torsemide ER 61 drug pipeline TAFA# 61 Neuradiab 61 Taxotere ® 61 OMS#HP 60 eosinophilic asthma 60 AGILECT R 60 IDX# 60 ridaforolimus 60 cangrelor 60 synthetic retinoid 60 talabostat 60 GLPG# 60 preclinically 60 peginterferon alfa 60 bazedoxifene 60 Troxatyl 60 generation PNP inhibitor 60 JAK2 Inhibitor 60 nab paclitaxel 60 ofatumumab HuMax CD# 60 Virulizin 60 intranasal formulation 60 TASQ 60 RIGScan CR 60 DexaSite 60 paclitaxel Taxol 60 Onalta ™ 60 Phase III Clinical Trial 60 CCR5 antagonist 60 Zemiva ™ 60 Pegasys peginterferon alfa 2a 60 Multiple Ascending Dose 60 ThermoDox R 60 Phase Ib IIa 60 TPI ASM8 60 etanercept Enbrel 60 erlotinib Tarceva ® 60 Hedgehog antagonist 60 Torisel 60 Vicinium TM 60 dose cohort 60 lupus nephritis 60 primary hypercholesterolemia 60 Forodesine HCl 60 CRLX# 60 SinuNase ™ 60 laquinimod 60 lixisenatide 60 valopicitabine 60 LAF# 60 farletuzumab 60 docetaxel chemotherapy 60 Lubiprostone 60 tasimelteon 60 lapatinib Tykerb 60 Enzastaurin 60 GFT# 60 Daclizumab 60 histamine dihydrochloride 60 Valopicitabine 60 investigational hepatitis C 60 Phase IIa clinical 60 infusional 5-FU/LV 60 Civacir 60 Elotuzumab 60 Meets Primary Endpoint 60 initiated Phase Ib 60 Phase III trials 60 Temsirolimus 60 Arcalyst 60 Oracea TM 60 TriLipix 60 Kuvan R 60 PEGylated interferon 60 Zalbin 60 Peginterferon alfa 2b 60 alkylating agent 60 Amitiza 60 EmbraceAC 60 dyskinesia PD LID 60 TYZEKA 60 Clevudine 60 ospemifene 60 Adentri 60 LUVENIQ 60 MyVax R 60 liposomal formulation 60 Apoptone 60 nucleoside reverse transcriptase inhibitor 60 unique alkylating agent 60 tocilizumab 60 cetuximab Erbitux 60 MEK Inhibitor 60 diarrhea predominant irritable 60 tolerability profiles 60 orBec 60 mg kg BID 60 LEP ETU 60 forodesine hydrochloride 60 CCR5 mAb 60 Aloxi injection 60 Exelixis compounds 60 BioVant 60 dacetuzumab SGN 60 Alinia 60 ritonavir boosted danoprevir 60 refractory multiple myeloma 60 dependent kinase inhibitor 60 DermaVir Patch 60 Phase 1a 60 metastatic HRPC 60 LEVADEX TM 60 ORENCIA ® 60 oral rivaroxaban 60 ALVESCO HFA 60 Vernakalant 60 CA4P 60 pediatric acute lymphoblastic 60 oral proteasome inhibitor 60 Irinotecan 60 standard chemotherapy regimen 60 Urocidin TM 60 sitaxsentan 60 initiate Phase Ib 60 Onco TCS 60 CytoFabTM 60 Prodarsan ® 60 S/GSK# 60 dimebon latrepirdine 60 Phase Ib clinical trials 60 HDAC Inhibitor 60 multi kinase inhibitor 60 Omigard 60 LUNESTA TM 60 preclinical pharmacokinetic 60 ThermoDox ® clinical 60 Completes Patient Enrollment 60 GetGoal Phase III 60 cetrorelix 60 AKT inhibitor 60 blinded randomized placebo controlled 60 Prestara 60 GRN# 60 velafermin belinostat 60 Zemiva TM 60 Alpharadin 60 delta opioid receptor 60 Cetrorelix 60 tubulin inhibitor 60 Serdaxin 60 dimebon 60 inhaled AAT 60 urocortin 2 60 Metastatic Melanoma 60 axitinib 60 ZYBRESTAT fosbretabulin 60 EP #R 60 MEND CABG II 60 ONCONASE R 60 trastuzumab Herceptin 60 Phase 1b clinical 60 Menerba 60 XP# XP# 60 REG1 Anticoagulation System 60 elacytarabine 60 aclidinium bromide 60 JAK inhibitors 60 carfilzomib 60 ritonavir boosting 60 Inhalation Solution 60 Frova ® 60 REMINYL ® 60 preclinical efficacy 60 Phase 1b clinical trials 60 INT# [002] 60 preclinical toxicology 60 octreotide acetate 60 REYATAZ R 60 Ecallantide 60 Diabetic Macular Edema 60 ISTODAX 60 glucokinase activator 60 ZACTIMA 60 oral calcitonin 60 Ketotransdel 60 CLIRS trial 60 catheter occlusion 60 Phase 2a clinical trials 60 ocular formulation 60 tolevamer 60 AQ4N 60 telbivudine 60 Perforomist ™ Inhalation Solution 60 fusion inhibitor 60 metastatic CRC 60 IMGN# 60 adipiplon 60 bevacizumab Avastin 60 phase Ib clinical 60 ALS #-# 60 fosbretabulin 60 mGluR2 positive 60 nucleotide analog 60 PYY #-# 60 cariprazine 60 Syncria 60 Squalamine 60 Fabry Disease 60 PrevOnco ™ 60 Orazol 60 Saxagliptin 60 Rebif ® 60 Naproxcinod 60 SYMMETRY trial 60 radezolid 60 xanthine oxidase inhibitor 60 darinaparsin 60 TH# [003] 60 Randomized Double blind 60 Topical Interferon Alpha 2b 60 hyperphenylalaninemia HPA due 60 Phase 2a Study 60 L BLP# 60 Blinatumomab 60 Telintra 60 Pafuramidine 60 infliximab Remicade 60 Marqibo TM 60 CRMD# 60 Ceplene TM 60 TORISEL 60 Milnacipran 60 #ME# 60 seliciclib 60 systemically administered 60 ONTAK 60 Revlimid lenalidomide 60 PREZISTA r 60 figitumumab 60 ostarine 60 resminostat 60 protein tyrosine phosphatase 1B 60 MoxDuo TM IR 60 Candesartan 60 ongoing Phase IIIb 60 ACAPODENE 60 peginesatide 60 SRT# [003] 60 Telatinib 60 generation URAT1 inhibitor 60 MabThera rituximab 60 PROVENGE ® 60 HCV protease inhibitors 60 panitumumab Vectibix 60 Riquent 60 BYETTA ® 60 Optiquel ™ 60 RAPAFLO 60 Maribavir 59 RSD# 59 MNTX 59 EXPAREL ™ 59 oxypurinol 59 IV Busulfex 59 selective modulator 59 Pegylated Interferon 59 bortezomib Velcade R 59 CHAMPION PCI 59 novel nucleoside analog 59 perampanel 59 Pyridorin TM 59 ISENTRESS 59 PRE SURGE 59 Bayer HealthCare Onyx Pharmaceuticals 59 oral Xeloda 59 crizotinib PF # 59 hepatitis C protease inhibitor 59 uric acid lowering 59 Relovair 59 HoFH 59 LE DT 59 ELND-#/AZD-# 59 Xinlay 59 next generation URAT1 59 #D#C#